What happens to NAD+ during an infusion? A metabolism pilot study
Study model: Humans; small pharmacokinetic pilot
The research question
Before assessing a potential effect, it is useful to know how an administered substance behaves. This pilot investigated changes in blood and urine during an NAD+ infusion.
What was found?
Researchers monitored NAD+ and related metabolites during and after a six-hour infusion. The study describes the processing and excretion of the substance. It was not a controlled study of stopping alcohol, nicotine, or other substances.
What does this evidence mean?
Metabolism data can help design follow-up research. They do not show whether a patient experiences fewer withdrawal symptoms or relapses less often. This article should be regarded as background information for NAD+ research and must not be used as evidence of efficacy for addiction treatment.
Primary source
Research information, not medical advice. The described study does not establish safe use of an investigational product. Image: AI illustration, not a participant or a photograph from the study.
Related research products
View product specifications and available batch documentation. The studies discussed were not conducted with Peptidera products and do not prove the efficacy of our products. For laboratory research only; not for human or animal consumption.